These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34332889)

  • 21. Layer-specific longitudinal strain predicts left ventricular maximum wall thickness in patients with hypertrophic cardiomyopathy.
    Tsugu T; Nagatomo Y; Dulgheru R; Lancellotti P
    Echocardiography; 2021 Jul; 38(7):1149-1156. PubMed ID: 34028870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mode of splitting of the second heart sound in patients with hypertrophic cardiomyopathy].
    Fukuda N; Oki T; Sakai H; Asai M; Ohshima C; Kusaka Y; Tominaga T; Murao A; Niki T; Mori H
    J Cardiogr; 1983 Jun; 13(2):327-41. PubMed ID: 6687124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microcirculatory dysfunction in hypertrophic cardiomyopathy with chest pain assessed by angiography-derived microcirculatory resistance.
    Lu Y; Xue ZK; Gao W; Bai G; Zhang X; Chen KY; Li G
    Sci Rep; 2024 Jul; 14(1):16977. PubMed ID: 39043796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of coronary flow with transthoracic color Doppler echocardiography in patients with hypertrophic cardiomyopathy.
    Ferreiro DE; Cianciulli TF; Saccheri MC; Lax JA; Celano L; Beck MA; Gagliardi JA; Kazelián LR; Neme RO
    Echocardiography; 2013 Nov; 30(10):1156-63. PubMed ID: 23662893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiographic strain in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy.
    Sun JP; Xu TY; Ni XD; Yang XS; Hu JL; Wang SC; Li Y; Bahler RC; Wang JG
    Echocardiography; 2019 Feb; 36(2):257-265. PubMed ID: 30561121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
    Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
    Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
    Timmer SA; Knaapen P; Germans T; Dijkmans PA; Lubberink M; Ten Berg JM; Ten Cate FJ; Rüssel IK; Götte MJ; Lammertsma AA; van Rossum AC
    Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H129-37. PubMed ID: 21490327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive assessment of microvascular function in patients with valvular heart disease.
    Nishi T; Kitahara H; Saito Y; Nishi T; Nakayama T; Fujimoto Y; Matsumiya G; Kobayashi Y
    Coron Artery Dis; 2018 May; 29(3):223-229. PubMed ID: 29215470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.
    Kim SW; Park SW; Lim SH; Kwon SU; Choi YJ; Park MK; Lee SC; Lee SH; Park JE; Jeon ES
    Clin Cardiol; 2006 Apr; 29(4):155-60. PubMed ID: 16649724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
    Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
    J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diastolic coronary vascular reserve: a new index to detect changes in the coronary microcirculation in hypertrophic cardiomyopathy.
    Krams R; Ten Cate FJ; Carlier SG; Van Der Steen AF; Serruys PW
    J Am Coll Cardiol; 2004 Feb; 43(4):670-7. PubMed ID: 14975481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.
    Badran HM; Faheem N; Ibrahim WA; Elnoamany MF; Elsedi M; Yacoub M
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1397-406. PubMed ID: 24094559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy.
    Ciampi Q; Betocchi S; Lombardi R; Manganelli F; Storto G; Losi MA; Pezzella E; Finizio F; Cuocolo A; Chiariello M
    J Am Coll Cardiol; 2002 Jul; 40(2):278-84. PubMed ID: 12106932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise speckle-tracking strain imaging demonstrates impaired right ventricular contractile reserve in hypertrophic cardiomyopathy.
    D'Andrea A; Limongelli G; Baldini L; Verrengia M; Carbone A; Di Palma E; Vastarella R; Masarone D; Tagliamonte G; Riegler L; Calabrò R; Russo MG; Bossone E; Pacileo G
    Int J Cardiol; 2017 Jan; 227():209-216. PubMed ID: 27839803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic Cardiomyopathy (HCM): New insights into Coronary artery remodelling and ischemia from FFR
    Sellers SL; Fonte TA; Grover R; Mooney J; Weir-McCall J; Lau KP; Chavda A; McNabney C; Ahmadi A; Blanke P; Payne GW; Murphy DT; Ong K; Taylor CA; Leipsic JA
    J Cardiovasc Comput Tomogr; 2018; 12(6):467-471. PubMed ID: 30139668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristic myocardial strain identified in hypertrophic cardiomyopathy subjects with preserved left ventricular ejection fraction using a novel multi-layer transthoracic echocardiography technique.
    Ozawa K; Funabashi N; Takaoka H; Kamata T; Kanaeda A; Saito M; Nomura F; Kobayashi Y
    Int J Cardiol; 2015 Apr; 184():237-243. PubMed ID: 25723651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceleration time of systolic coronary flow velocity to diagnose coronary stenosis in patients with microvascular dysfunction.
    Takemoto K; Hirata K; Wada N; Shiono Y; Komukai K; Tanimoto T; Ino Y; Kitabata H; Takarada S; Nakamura N; Kubo T; Tanaka A; Imanishi T; Akasaka T
    J Am Soc Echocardiogr; 2014 Feb; 27(2):200-7. PubMed ID: 24345631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in coronary blood flow dynamics between patients with hypertension and those with hypertrophic cardiomyopathy.
    Misawa K; Nitta Y; Matsubara T; Oe K; Kiyama M; Shimizu M; Mabuchi H
    Hypertens Res; 2002 Sep; 25(5):711-6. PubMed ID: 12452323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.